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Oral hairy leukoplakia occurs on the lateral surface of the tongue that clinically as an asymp-
tomatic white lesion. It is mainly found in patient with human immunodeficiency virus infec-
tion. However, it rarely outbreak immunosuppressed patients after organ transplantation, or 
the patients taking steroids or immunosuppressants. It is the result of proliferating Epstein-Barr 
virus in the oral epithelium. Most of human immunodeficiency virus infected patients with oral 
hairy leukoplakia are highly contagious and possible to progress acquired immunodeficiency 
syndrome. Therefore, the early diagnosis of oral hairy leukoplakia is very important. Taking a 
thorough history and human immunodeficiency virus screening test is highly recommended in 
case oral hairy leukoplakia is detected. In this case, a 29-year-old man presented with whitish 
lesion on lateral border of tongue is diagnosed as oral hairy leukoplakia and human immuno-
deficiency virus infection. 
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INTRODUCTION
Oral hairy leukoplakia (OHL) typically occurs on the lat-
eral surface of the tongue as a painless whitish plaque that 
is not removable by rubbing. OHL is known to be caused by 
Epstein-Barr virus (EBV; human herpesvirus-4) infection.1-3) It 
is mainly found in patients infected with human immuno-
deficiency virus (HIV).4)
In this case, a 29-year-old man with a lesion on the lat-
eral borders of the tongue was screened and diagnosed with 
HIV infection.
CASE REPORT
A 29-year-old man presented with whitish lesion of 
tongue. The lesion developed 4 months ago. He had no his-
tory of systemic disease and had not taken any medication. 
He was healthy and a nonsmoker.
Clinical examination revealed whitish plaque with co rru gated 
and hairy surface on the lateral border of tongue (Fig. 1). It 
was not tender when palpated and not removed by rubbing.
It was clinically diagnosed as OHL. In order to determine 
HIV infection, OraQuick ADVANCE rapid HIV-1/2 antibody 
test (OraSure Technologies, Bethlehem, PA, USA) was car-
ried out. It showed a positive result. Then consultation to 
the division of infectious diseases was done for the definite 
diagnosis and treatment. For the treatment of intraoral le-
sion, acyclovir cream (Zovirax; Dong-A ST, Seoul, Korea) 
was topically applied.
After 1 week, it was not improved by topical application 
of acyclovir. Finally, he was diagnosed with HIV infection 
by serologic test. EBV antibodies were detected in the serum 
of the patient, and CD4+ T cell was significantly decreased 
(3/µL). After that, he had been receiving antiretroviral 
therapy.
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DISCUSSION
OHL could be classed as an opportunistic disease by the 
EBV proliferating in keratinized epithelium of immunocom-
promised patients.5,6) OHL has been also described in other 
immunocompromised individuals, including organ trans-
plant recipients or the person undergoing steroid or immu-
nosuppressive therapy.4,5,7) But OHL in smokers and immu-
nocompetent patients has been also reported.8)
In clinical practice, it is important to differentiate the le-
sion which presents as whitish plaque from other oral lesion 
that may have a similar clinical appearance. The differential 
diagnosis of OHL should include candidiasis, lichen planus, 
leukoplakia, and squamous cell carcinoma. The diagnosis of 
OHL is not difficult because it is observed as a non-remov-
able whitish lesion on the lateral border of the tongue. A 
simple chair-side screening tool, OraQuick ADVANCE rapid 
HIV-1/2 antibody test, is a point-of-care test to aid in the 
diagnosis of HIV infection with accuracy (Table 1).9-12)
Treatment is seldom required since OHL is usually symp-
tomless and self-limiting. There are few studies about the 
treatments for OHL.5,13-15) It was reported that combination 
therapy of 25% podophyllin and 5% acyclovir cream is the 
most effective method to manage OHL.6,16) 
Most of HIV infected patients with OHL are highly conta-
gious and possible to progress acquired immunodeficiency 
syndrome. The early diagnosis of HIV infection is critical 
since HIV can be transmitted from HIV-infected people who 
do not know their status to others. OHL may be an early 
indicator of undiagnosed HIV infection or prognostic in-
dicator of immunocompromised status. Therefore, dentists 
should acquire the essential knowledge of OHL. Taking a 
thorough history and HIV screening test is highly recom-
mended in case OHL is detected. 
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